Curis director converts preferred into common stock
Curis Inc director Marc Rubin converted preferred stock into common shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Curis Inc director Marc Rubin converted preferred stock into common shares. On March 20, 2026, he converted 20 shares of Series B Convertible Preferred Stock into 26,667 shares of Common Stock for no additional consideration through an automatic conversion.
Following the conversion, Rubin directly owned 28,108 shares of Curis Common Stock. The preferred shares were originally sold as part of a $1,000.00 "Security" unit that also included Series A, B and C warrants, and converted subject to stated beneficial ownership limitations.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Series B Convertible Preferred Stock | 20 | $0.00 | $0.00 |
| Conversion | Common Stock | 26,667 | $0.00 | $0.00 |
Footnotes (1)
- F1. Each share of Series B Convertible Non-Redeemable Preferred Stock ("Series B Preferred Stock") automatically converted into 1,333.33 shares of Common Stock, for no additional consideration, at 5 p. m. Eastern Time on March 20, 2026, subject to the terms of the Certificate of Designations, Preferences and Rights of Series B Convertible Non-Redeemable Preferred Stock of Curis, Inc. (the "Certificate of Designations") and subject to the applicable Beneficial Ownership Limitations (as defined in the Certificate of Designations). Each share of Series B Preferred Stock was sold together with a Series A Warrant to purchase 1,333.33 shares of Common Stock, a Series B Warrant to purchase 1,333.33 shares of Common Stock and a Series C Warrant to purchase 1,333.33 shares of Common Stock (collectively, a "Security"). The Securities were sold at a purchase price of $1,000.00 per Security to the Reporting Person.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Curis (CRIS) report in this Form 4?
What were the terms of the Curis Series B Preferred Stock conversion for Marc Rubin?
At what price were the Curis Series B Preferred Securities originally sold to Marc Rubin?
Does Marc Rubin retain any Series B Preferred Stock of Curis after this transaction?
Were there any cash proceeds to Marc Rubin from this Curis stock conversion?
AI-generated analysis. How Rhea-AI works. Not financial advice.